Shabelnyk, K.; Fominichenko, A.; Antypenko, O.; Gaponov, O.; Koptieva, S.; Shyshkina, S.; Voskoboinik, O.; Okovytyy, S.; Kovalenko, S.; Oksenych, V.;
et al. Antistaphylococcal Triazole-Based Molecular Hybrids: Design, Synthesis and Activity. Pharmaceuticals 2025, 18, 83.
https://doi.org/10.3390/ph18010083
AMA Style
Shabelnyk K, Fominichenko A, Antypenko O, Gaponov O, Koptieva S, Shyshkina S, Voskoboinik O, Okovytyy S, Kovalenko S, Oksenych V,
et al. Antistaphylococcal Triazole-Based Molecular Hybrids: Design, Synthesis and Activity. Pharmaceuticals. 2025; 18(1):83.
https://doi.org/10.3390/ph18010083
Chicago/Turabian Style
Shabelnyk, Kostiantyn, Alina Fominichenko, Oleksii Antypenko, Olexandr Gaponov, Svitlana Koptieva, Svitlana Shyshkina, Oleksii Voskoboinik, Sergiy Okovytyy, Serhii Kovalenko, Valentyn Oksenych,
and et al. 2025. "Antistaphylococcal Triazole-Based Molecular Hybrids: Design, Synthesis and Activity" Pharmaceuticals 18, no. 1: 83.
https://doi.org/10.3390/ph18010083
APA Style
Shabelnyk, K., Fominichenko, A., Antypenko, O., Gaponov, O., Koptieva, S., Shyshkina, S., Voskoboinik, O., Okovytyy, S., Kovalenko, S., Oksenych, V., & Kamyshnyi, O.
(2025). Antistaphylococcal Triazole-Based Molecular Hybrids: Design, Synthesis and Activity. Pharmaceuticals, 18(1), 83.
https://doi.org/10.3390/ph18010083